{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:39:34Z","timestamp":1789605574269,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2007,11,19]],"date-time":"2007-11-19T00:00:00Z","timestamp":1195430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,11,19]],"date-time":"2007-11-19T00:00:00Z","timestamp":1195430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2008,5,1]]},"DOI":"10.1038\/sj.onc.1210943","type":"journal-article","created":{"date-parts":[[2007,11,19]],"date-time":"2007-11-19T11:41:50Z","timestamp":1195472510000},"page":"2868-2876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Enforced epithelial expression of IGF-1 causes hyperplastic prostate growth while negative selection is requisite for spontaneous metastogenesis"],"prefix":"10.1038","volume":"27","author":[{"given":"P J","family":"Kaplan-Lefko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B W","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A I","family":"Evangelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D L","family":"Hadsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R J","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B A","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"DeMayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N M","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,19]]},"reference":[{"key":"BF1210943_CR1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/1078-0432.206.11.1","volume":"11","author":"J Ahlen","year":"2005","unstructured":"Ahlen J, Wejde J, Brosjo O, von Rosen A, Weng WH, Girnita L et al. (2005). Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma. Clin Cancer Res 11: 206\u2013216.","journal-title":"Clin Cancer Res"},{"key":"BF1210943_CR2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nature06027","volume":"448","author":"SC Bendall","year":"2007","unstructured":"Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, Werbowetski-Ogilvie T et al. (2007). IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448: 1015\u20131021.","journal-title":"Nature"},{"key":"BF1210943_CR3","doi-asserted-by":"publisher","first-page":"7180","DOI":"10.1073\/pnas.0502761102","volume":"102","author":"PE Burger","year":"2005","unstructured":"Burger PE, Xiong X, Coetzee S, Salm SN, Moscatelli D, Goto K et al. (2005). Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci USA 102: 7180\u20137185.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210943_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1046\/j.1464-410X.1996.09721.x","volume":"77","author":"RL Byrne","year":"1996","unstructured":"Byrne RL, Leung H, Neal DE . (1996). Peptide growth factors in the prostate as mediators of stromal epithelial interaction. Br J Urol 77: 627\u2013633.","journal-title":"Br J Urol"},{"key":"BF1210943_CR5","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1158\/0008-5472.CAN-04-4602","volume":"65","author":"JM Carboni","year":"2005","unstructured":"Carboni JM, Lee AV, Hadsell DL, Rowley BR, Lee FY, Bol DK et al. (2005). Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res 65: 3781\u20133787.","journal-title":"Cancer Res"},{"key":"BF1210943_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1126\/science.279.5350.563","volume":"279","author":"JM Chan","year":"1998","unstructured":"Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P et al. (1998). Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563\u2013566.","journal-title":"Science"},{"key":"BF1210943_CR7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/jnci\/94.14.1099","volume":"94","author":"JM Chan","year":"2002","unstructured":"Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M et al. (2002). Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 94: 1099\u20131106.","journal-title":"J Natl Cancer Inst"},{"key":"BF1210943_CR8","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1021\/bi00591a005","volume":"18","author":"JM Chirgwin","year":"1979","unstructured":"Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ . (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294\u20135299.","journal-title":"Biochemistry"},{"key":"BF1210943_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S0002-9440(10)65229-7","volume":"155","author":"A Chott","year":"1999","unstructured":"Chott A, Sun Z, Morganstern D, Pan J, Li T, Susani M et al. (1999). Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor. Am J Pathol 155: 1271\u20131279.","journal-title":"Am J Pathol"},{"key":"BF1210943_CR10","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1210\/jcem.84.6.5776","volume":"84","author":"A Colao","year":"1999","unstructured":"Colao A, Marzullo P, Spiezia S, Ferone D, Giaccio A, Cerbone G et al. (1999). Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects. J Clin Endocrinol Metab 84: 1986\u20131991.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1210943_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-4613-1595-7_9","volume":"46","author":"GR Cunha","year":"1989","unstructured":"Cunha GR, Donjacour AA . (1989). Mesenchymal-epithelial interactions in the growth and development of the prostate. Cancer Treat Res 46: 159\u2013175.","journal-title":"Cancer Treat Res"},{"key":"BF1210943_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1210\/endo.142.1.7890","volume":"142","author":"SE Damon","year":"2001","unstructured":"Damon SE, Plymate SR, Carroll JM, Sprenger CC, Dechsukhum C, Ware JL et al. (2001). Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells. Endocrinology 142: 21\u201327.","journal-title":"Endocrinology"},{"key":"BF1210943_CR13","first-page":"1561","volume":"60","author":"J DiGiovanni","year":"2000","unstructured":"DiGiovanni J, Bol DK, Wilker E, Beltran L, Carbajal S, Moats S et al. (2000a). Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res 60: 1561\u20131570.","journal-title":"Cancer Res"},{"key":"BF1210943_CR14","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1073\/pnas.97.7.3455","volume":"97","author":"J DiGiovanni","year":"2000","unstructured":"DiGiovanni J, Kiguchi K, Frijhoff A, Wilker E, Bol DK, Beltran L et al. (2000b). Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci USA 97: 3455\u20133460.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210943_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcb.10771","volume":"91","author":"AI Evangelou","year":"2004","unstructured":"Evangelou AI, Winter SF, Huss WJ, Bok RA, Greenberg NM . (2004). Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype. J Cell Biochem 91: 671\u2013683.","journal-title":"J Cell Biochem"},{"key":"BF1210943_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00345-003-0395-3","volume":"22","author":"K Forbes","year":"2004","unstructured":"Forbes K, Gillette K, Kelley LA, Sehgal I . (2004). Increased levels of urokinase plasminogen activator receptor in prostate cancer cells derived from repeated metastasis. World J Urol 22: 67\u201371.","journal-title":"World J Urol"},{"key":"BF1210943_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/path.1712","volume":"205","author":"E Foulstone","year":"2005","unstructured":"Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J, Jacobs C et al. (2005). Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J Pathol 205: 145\u2013153.","journal-title":"J Pathol"},{"key":"BF1210943_CR18","first-page":"4096","volume":"56","author":"JR Gingrich","year":"1996","unstructured":"Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ et al. (1996). Metastatic prostate cancer in a transgenic mouse. Cancer Res 56: 4096\u20134102.","journal-title":"Cancer Res"},{"key":"BF1210943_CR19","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1073\/pnas.92.8.3439","volume":"92","author":"NM Greenberg","year":"1995","unstructured":"Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO et al. (1995). Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92: 3439\u20133443.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210943_CR20","first-page":"230","volume":"8","author":"NM Greenberg","year":"1994","unstructured":"Greenberg NM, DeMayo FJ, Sheppard PC, Barrios R, Lebovitz R, Finegold M et al. (1994). The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 8: 230\u2013239.","journal-title":"Mol Endocrinol"},{"key":"BF1210943_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1210\/endo.137.1.8536631","volume":"137","author":"DL Hadsell","year":"1996","unstructured":"Hadsell DL, Greenberg NM, Fligger JM, Baumrucker CR, Rosen JM . (1996). Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology 137: 321\u2013330.","journal-title":"Endocrinology"},{"key":"BF1210943_CR22","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/sj.onc.1203386","volume":"19","author":"DL Hadsell","year":"2000","unstructured":"Hadsell DL, Murphy KL, Bonnette SG, Reece N, Laucirica R, Rosen JM . (2000). Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis. Oncogene 19: 889\u2013898.","journal-title":"Oncogene"},{"key":"BF1210943_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/sj.pcan.4500745","volume":"7","author":"DL Hudson","year":"2004","unstructured":"Hudson DL . (2004). Epithelial stem cells in human prostate growth and disease. Prostate Cancer Prostatic Dis 7: 188\u2013194.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"BF1210943_CR24","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1158\/0008-5472.CAN-04-2548","volume":"65","author":"WJ Huss","year":"2005","unstructured":"Huss WJ, Gray DR, Greenberg NM, Mohler JL, Smith GJ . (2005). Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells. Cancer Res 65: 6640\u20136650.","journal-title":"Cancer Res"},{"key":"BF1210943_CR25","first-page":"2203","volume":"59","author":"PJ Kaplan","year":"1999","unstructured":"Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM . (1999). The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res 59: 2203\u20132209.","journal-title":"Cancer Res"},{"key":"BF1210943_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/pros.10215","volume":"55","author":"PJ Kaplan-Lefko","year":"2003","unstructured":"Kaplan-Lefko PJ, Chen TM, Ittmann MM, Barrios RJ, Ayala GE, Huss WJ et al. (2003). Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 55: 219\u2013237.","journal-title":"Prostate"},{"key":"BF1210943_CR27","doi-asserted-by":"publisher","first-page":"11563","DOI":"10.1073\/pnas.201167798","volume":"98","author":"B Kwabi-Addo","year":"2001","unstructured":"Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N et al. (2001). Haploinsufficiency of the PTEN tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci USA 98: 11563\u201311568.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210943_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1155\/EDR.2003.205","volume":"4","author":"D Le Roith","year":"2003","unstructured":"Le Roith D . (2003). The insulin-like growth factor system. Exp Diabesity Res 4: 205\u2013212.","journal-title":"Exp Diabesity Res"},{"key":"BF1210943_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0304-3835(03)00159-9","volume":"195","author":"D Le Roith","year":"2003","unstructured":"Le Roith D, Roberts Jr CT . (2003). The insulin-like growth factor system and cancer. Cancer Lett 195: 127\u2013137.","journal-title":"Cancer Lett"},{"key":"BF1210943_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/scbi.1997.0048","volume":"8","author":"D MacGrogan","year":"1997","unstructured":"MacGrogan D, Bookstein R . (1997). Tumour suppressor genes in prostate cancer. Semin Cancer Biol 8: 11\u201319.","journal-title":"Semin Cancer Biol"},{"key":"BF1210943_CR31","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1038\/sj.onc.1208572","volume":"24","author":"N Majeed","year":"2005","unstructured":"Majeed N, Blouin MJ, Kaplan-Lefko PJ, Barry-Shaw J, Greenberg NM, Gaudreau P et al. (2005). A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model. Oncogene 24: 4736\u20134740.","journal-title":"Oncogene"},{"key":"BF1210943_CR32","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.1073\/pnas.0609139104","volume":"104","author":"R Mehrian-Shai","year":"2007","unstructured":"Mehrian-Shai R, Chen CD, Shi T, Horvath S, Nelson SF, Reichardt JK et al. (2007). Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K\/Akt pathway activation in glioblastoma and prostate cancer. Proc Natl Acad Sci USA 104: 5563\u20135568.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210943_CR33","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.1158\/1078-0432.CCR-04-0430","volume":"10","author":"M Nakamura","year":"2004","unstructured":"Nakamura M, Miyamoto S, Maeda H, Zhang SC, Sangai T, Ishii G et al. (2004). Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers. Clin Cancer Res 10: 8434\u20138441.","journal-title":"Clin Cancer Res"},{"key":"BF1210943_CR34","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1210\/endo.132.3.7679979","volume":"132","author":"Y Oh","year":"1993","unstructured":"Oh Y, Muller HL, Lee DY, Fielder PJ, Rosenfeld RG . (1993). Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1\u20134 for IGF-I, IGF-II, IGF-I\/insulin hybrid, and IGF-I analogs. Endocrinology 132: 1337\u20131344.","journal-title":"Endocrinology"},{"key":"BF1210943_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10552-004-3484-8","volume":"16","author":"EA Platz","year":"2005","unstructured":"Platz EA, Pollak MN, Leitzmann MF, Stampfer MJ, Willett WC, Giovannucci E . (2005). Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era. Cancer Causes Control 16: 255\u2013262.","journal-title":"Cancer Causes Control"},{"key":"BF1210943_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/pros.20099","volume":"61","author":"SR Plymate","year":"2004","unstructured":"Plymate SR, Tennant MK, Culp SH, Woodke L, Marcelli M, Colman I et al. (2004). Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors. Prostate 61: 276\u2013290.","journal-title":"Prostate"},{"key":"BF1210943_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrc1387","volume":"4","author":"MN Pollak","year":"2004","unstructured":"Pollak MN, Schernhammer ES, Hankinson SE . (2004). Insulin-like growth factors and neoplasia. Nat Rev Cancer 4: 505\u2013518.","journal-title":"Nat Rev Cancer"},{"key":"BF1210943_CR38","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/sj.onc.1203587","volume":"19","author":"K Reiss","year":"2000","unstructured":"Reiss K, Wang JY, Romano G, Furnari FB, Cavenee WK, Morrione A et al. (2000). IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation. Oncogene 19: 2687\u20132694.","journal-title":"Oncogene"},{"key":"BF1210943_CR39","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","volume":"363","author":"AG Renehan","year":"2004","unstructured":"Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M . (2004). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363: 1346\u20131353.","journal-title":"Lancet"},{"key":"BF1210943_CR40","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F","volume":"89","author":"B Schnarr","year":"2000","unstructured":"Schnarr B, Strunz K, Ohsam J, Benner A, Wacker J, Mayer D . (2000). Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer. Int J Cancer 89: 506\u2013513.","journal-title":"Int J Cancer"},{"key":"BF1210943_CR41","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1200\/JCO.2000.18.4.847","volume":"18","author":"T Shaneyfelt","year":"2000","unstructured":"Shaneyfelt T, Husein R, Bubley G, Mantzoros CS . (2000). Hormonal predictors of prostate cancer: a meta-analysis. J Clin Oncol 18: 847\u2013853.","journal-title":"J Clin Oncol"},{"key":"BF1210943_CR42","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1158\/0008-5472.CAN-03-0946","volume":"64","author":"SB Shappell","year":"2004","unstructured":"Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA et al. (2004). Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 64: 2270\u20132305.","journal-title":"Cancer Res"},{"key":"BF1210943_CR43","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1172\/JCI119820","volume":"100","author":"H Wennbo","year":"1997","unstructured":"Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J . (1997a). Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 100: 2744\u20132751.","journal-title":"J Clin Invest"},{"key":"BF1210943_CR44","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1210\/endo.138.10.5461","volume":"138","author":"H Wennbo","year":"1997","unstructured":"Wennbo H, Kindblom J, Isaksson OG, Tornell J . (1997b). Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 138: 4410\u20134415.","journal-title":"Endocrinology"},{"key":"BF1210943_CR45","first-page":"4936","volume":"63","author":"X Wu","year":"2003","unstructured":"Wu X, Jin C, Wang F, Yu C, McKeehan WL . (2003). Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors. Cancer Res 63: 4936\u20134944.","journal-title":"Cancer Res"},{"key":"BF1210943_CR46","doi-asserted-by":"publisher","first-page":"6942","DOI":"10.1073\/pnas.0502320102","volume":"102","author":"L Xin","year":"2005","unstructured":"Xin L, Lawson DA, Witte ON . (2005). The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 102: 6942\u20136947.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210943_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000085718","volume":"9","author":"S Yakar","year":"2005","unstructured":"Yakar S, Pennisi P, Wu Y, Zhao H, LeRoith D . (2005). Clinical relevance of systemic and local IGF-I. Endocr Dev 9: 11\u201316.","journal-title":"Endocr Dev"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1210943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1210943","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1210943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T20:48:02Z","timestamp":1684097282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1210943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,19]]},"references-count":47,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2008,5,1]]}},"alternative-id":["BF1210943"],"URL":"https:\/\/doi.org\/10.1038\/sj.onc.1210943","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,19]]},"assertion":[{"value":"3 December 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}